IRIS
DRAGO, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.135
EU - Europa 14.459
AS - Asia 13.620
SA - Sud America 2.592
AF - Africa 1.297
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 23
Totale 58.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.141
SG - Singapore 7.221
RU - Federazione Russa 4.842
CN - Cina 4.286
IT - Italia 3.166
IE - Irlanda 2.371
BR - Brasile 2.250
UA - Ucraina 2.078
CA - Canada 843
CI - Costa d'Avorio 756
VN - Vietnam 654
SE - Svezia 454
KR - Corea 414
DE - Germania 384
SN - Senegal 276
IN - India 260
GB - Regno Unito 257
AR - Argentina 130
FR - Francia 129
FI - Finlandia 117
NL - Olanda 108
ES - Italia 100
PL - Polonia 94
JP - Giappone 91
BD - Bangladesh 88
MX - Messico 88
ZA - Sudafrica 87
CH - Svizzera 83
ID - Indonesia 74
HK - Hong Kong 65
TR - Turchia 64
UZ - Uzbekistan 61
EC - Ecuador 56
AT - Austria 55
IQ - Iraq 55
BE - Belgio 41
PK - Pakistan 41
GR - Grecia 40
IR - Iran 40
CO - Colombia 39
BJ - Benin 38
CZ - Repubblica Ceca 35
LB - Libano 34
VE - Venezuela 33
MA - Marocco 31
NG - Nigeria 31
PY - Paraguay 28
LT - Lituania 23
AU - Australia 21
EU - Europa 21
AE - Emirati Arabi Uniti 20
BG - Bulgaria 18
KE - Kenya 18
TN - Tunisia 18
IL - Israele 17
JO - Giordania 17
PE - Perù 17
SA - Arabia Saudita 17
AZ - Azerbaigian 16
JM - Giamaica 15
CL - Cile 14
EG - Egitto 13
UY - Uruguay 13
OM - Oman 12
DO - Repubblica Dominicana 10
PA - Panama 10
BO - Bolivia 9
DZ - Algeria 9
KZ - Kazakistan 9
NP - Nepal 9
RO - Romania 9
DK - Danimarca 8
HN - Honduras 8
TH - Thailandia 8
AL - Albania 7
PH - Filippine 6
TW - Taiwan 6
AO - Angola 5
HR - Croazia 5
MY - Malesia 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
RS - Serbia 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
ET - Etiopia 4
HU - Ungheria 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
CR - Costa Rica 3
GT - Guatemala 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
BB - Barbados 2
GE - Georgia 2
GH - Ghana 2
GY - Guiana 2
Totale 58.113
Salva come PNG Salva come JPEG
Città #
Dallas 4.727
Singapore 4.019
Santa Clara 3.187
Chandler 2.448
Jacksonville 2.373
Dublin 2.357
Moscow 1.918
Boardman 1.087
Chicago 978
Hefei 966
Ashburn 883
Catania 876
Abidjan 756
Houston 731
Nanjing 696
Lawrence 634
Cambridge 632
Andover 622
Toronto 599
Beijing 481
Los Angeles 409
Seoul 406
Des Moines 327
San Mateo 307
Dakar 276
Wilmington 273
Civitanova Marche 254
Nanchang 219
Ho Chi Minh City 201
Shenyang 191
São Paulo 188
New York 171
Hebei 163
Saint Petersburg 156
Jiaxing 154
Council Bluffs 151
Ottawa 151
Buffalo 143
Changsha 136
Hanoi 133
Tianjin 126
The Dalles 124
Bremen 111
Florence 110
Columbus 108
Rome 108
Palermo 105
Messina 104
Dong Ket 88
Tokyo 81
Grafing 76
Milan 76
Rio de Janeiro 76
Brooklyn 63
Munich 63
Warsaw 63
Denver 62
Seattle 60
Washington 58
Phoenix 56
Amsterdam 55
Hong Kong 55
Aci Catena 54
Johannesburg 50
Stockholm 48
Belo Horizonte 47
Hangzhou 47
Liberty Lake 47
Falls Church 45
Montreal 45
Norwalk 45
Orem 45
Pune 45
San Francisco 45
Jinan 44
Lappeenranta 44
Mumbai 42
San Jose 42
Chennai 41
Boston 40
Curitiba 39
London 39
Atlanta 38
Cotonou 38
Dearborn 37
Porto Alegre 37
Helsinki 35
Redondo Beach 34
Brasília 33
Brussels 32
Jakarta 31
Redwood City 31
Abuja 30
Kunming 30
Turku 30
Ann Arbor 29
Haiphong 29
Manchester 29
Mexico City 29
Poplar 29
Totale 38.682
Salva come PNG Salva come JPEG
Nome #
Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus. 555
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 254
Current drug treatments targeting dopamine D3 receptor 221
Dopaminergic-GABAergic interplay and alcohol binge drinking 210
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 203
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 192
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 192
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 181
Anorectal mucosal melanoma 178
Antioxidant and osmoprotecting activity of taurine in dry eye models 175
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 169
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 167
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 165
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 164
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 164
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 163
Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1 163
Antiproliferative effects of PACAP and VIP in serum-starved glioma cells 161
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 161
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 160
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 159
Clinical and neurocognitive predictors of functional outcome in depressed patients with partial response to treatment: One year follow-up study 158
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 156
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 155
A musician's dystonia 154
New psychometric strategies for the evaluation of affective, cognitive and psychosocial functioning in unipolar versus bipolar depression: impact of drug treatment 153
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 153
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 150
Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells 150
D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis 150
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 148
Caffeine Protects Against Retinal Inflammation 148
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 148
Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression? 148
Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice 147
Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key 146
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 146
21. Azione della prolattina e dei suoi frammenti sulle integrazioni psiconeuroendocrine. 145
(-)Deprenyl improves behavioral deficits of aged rats after oral administration. 144
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 144
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 144
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 142
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 142
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance 142
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 142
Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target 138
Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis 138
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 137
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 137
A key role for TGF-β1 in hippocampal synaptic plasticity and memory 136
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 134
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 134
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis 134
Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain. 132
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 128
Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure 127
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 126
An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: relation to cognitive decline and longitudinal evaluation 125
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 125
[Dopaminergic system in the retina of rabbits and its interaction with TRH] 124
Pericentrin expression in Down's syndrome 124
Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System 124
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 122
Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery 122
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 122
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 122
Controversies in Glaucoma: Current Medical Treatment and Drug Development 121
"Dopaminergic hypothesis for inhibited depression: a symptomatological profile for prediction of therapeutical responses". 121
Fluoxetine Protects Retinal Ischemic Damage in Mice 120
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 120
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study 120
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 120
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 119
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 118
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 118
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 117
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 117
Epigenetic drugs for Alzheimer's disease: hopes and challenges 117
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 117
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 116
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 116
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries 116
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 115
Memory deficits of age male rats can be improved by pyrimidine nucleosides and n-acetyl-glutamine 115
Astroglial CB1 Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory 115
Acetylcarnitine reduces the immobility of rats in a dispair test (costrained swim) 114
Dihydroergocryptine improves behavioral deficits of aged male rats 114
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 114
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 114
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 114
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 114
The Apathy Evaluation Scale (AES-C): Psychometric Properties and Invariance of Italian Version in Mild Cognitive Impairment and Alzheimer's Disease 114
Predictors of functional outcome in patients with major depression and bipolar disorder: a dynamic network approach to identify distinct patterns of interacting symptoms 113
[Penetration of labeled rifampicin into the rat parotid gland 113
A cannabinoid link between mitochondria and memory 113
APP expression in dopamine D3 receptor knock out mice brain during memory consolidation 113
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic epatiti C treated with pegylated interferon α and ribavirin 113
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 113
"Valutazione del behaviour motorio in condizioni di iperprolattinemia". 111
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 111
Totale 14.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 204.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.053 0 0 0 0 0 154 542 27 361 66 654 249
2021/20224.746 602 678 35 96 731 104 671 161 428 41 157 1.042
2022/20237.887 688 301 78 716 916 1.393 58 1.373 1.914 65 247 138
2023/20243.193 217 460 184 236 133 612 48 196 27 73 633 374
2024/202513.497 151 1.972 797 672 2.929 1.445 460 654 1.079 1.258 951 1.129
2025/202619.907 1.809 1.682 5.486 1.921 4.344 4.665 0 0 0 0 0 0
Totale 59.405